Each vial is sealed with a crimped aluminium cap and labelled according to our controlled research material standards
Sikiric P, Sever M, Krezic I, Vranes H, Kalogjera L, Smoday IM, et al
For individuals seeking FDA-approved treatments, guaranteed outcomes, or immediate acute injury intervention, BPC-157 is not the appropriate choice
Maintenance is typically every three months
We'll evaluate your injury, determine if BPC-157 is the right approach, and build a recovery protocol tailored to your situation
A third type of crystal-induced arthritis, hydroxyapatite deposition disease , has a type of crystal that needs special studies (one such study is electron microscopy) for identification